APRE (APREA THERAPEUTICS INC) — 2 tracked funds

Cross-fund · 2 holders

APRE

APREA THERAPEUTICS INC

CUSIP 03836J201

Tracked holders

$56,035

Aggregate value

66,590

Active funds

Funds holding APRE

Fund	Strategy	Period	Value	% of book	Δ shares	Status
Vanguard	Institutional	Q4 2025	$49,548	—	−100,152	−63.3%
BlackRock	Institutional	Q1 2026	$6,487	—	0	HELD
Citadel	Multi-Strategy	Q1 2026	—	—	−51,041	EXITED

Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.